In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Clearside Biomedical Inc (NASDAQ: CLSD) closed the day trading at $0.87 down -6.20% from the previous closing price of $0.93. In other words, the price has decreased by -$6.20 from its previous closing price. On the day, 0.94 million shares were traded. CLSD stock price reached its highest trading level at $0.9298 during the session, while it also had its lowest trading level at $0.801.
Ratios:
For a better understanding of CLSD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.49 and its Current Ratio is at 4.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on August 21, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 01 ’24 when Chong Ngai Hang Victor bought 36,500 shares for $1.00 per share. The transaction valued at 36,500 led to the insider holds 100,000 shares of the business.
Chong Ngai Hang Victor bought 23,500 shares of CLSD for $24,910 on Jun 24 ’24. The Chief Medical Officer now owns 63,500 shares after completing the transaction at $1.06 per share. On May 15 ’24, another insider, YERXA BENJAMIN R, who serves as the Director of the company, bought 7,813 shares for $1.31 each. As a result, the insider paid 10,235 and bolstered with 17,957 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 66158292 and an Enterprise Value of 98959216. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.06. Its current Enterprise Value per Revenue stands at 13.152 whereas that against EBITDA is -3.857.
Stock Price History:
Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is -18.27%, while the 200-Day Moving Average is calculated to be -28.44%.
Shares Statistics:
Over the past 3-months, CLSD traded about 714.16K shares per day on average, while over the past 10 days, CLSD traded about 351660 shares per day. A total of 74.75M shares are outstanding, with a floating share count of 64.24M. Insiders hold about 15.29% of the company’s shares, while institutions hold 15.96% stake in the company. Shares short for CLSD as of 1730332800 were 1757891 with a Short Ratio of 1.87, compared to 1727654400 on 261216. Therefore, it implies a Short% of Shares Outstanding of 1757891 and a Short% of Float of 2.5.
